MA39110A1 - Nouveau composé pour le traitement de l'hypoglycémie grave - Google Patents
Nouveau composé pour le traitement de l'hypoglycémie graveInfo
- Publication number
- MA39110A1 MA39110A1 MA39110A MA39110A MA39110A1 MA 39110 A1 MA39110 A1 MA 39110A1 MA 39110 A MA39110 A MA 39110A MA 39110 A MA39110 A MA 39110A MA 39110 A1 MA39110 A1 MA 39110A1
- Authority
- MA
- Morocco
- Prior art keywords
- treatment
- new compound
- severe hypoglycemia
- hypoglycemia
- severe
- Prior art date
Links
- 208000013016 Hypoglycemia Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 230000002218 hypoglycaemic effect Effects 0.000 title abstract 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
La présente invention concerne un nouveau composé utile dans le traitement de l'hypoglycémie.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361917716P | 2013-12-18 | 2013-12-18 | |
| PCT/US2014/069644 WO2015094876A1 (fr) | 2013-12-18 | 2014-12-11 | Nouveau composé pour le traitement de l'hypoglycémie grave |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA39110A1 true MA39110A1 (fr) | 2017-09-29 |
| MA39110B1 MA39110B1 (fr) | 2018-04-30 |
Family
ID=52273565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39110A MA39110B1 (fr) | 2013-12-18 | 2014-12-11 | Nouveau composé pour le traitement de l'hypoglycémie grave |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20160311882A1 (fr) |
| EP (1) | EP3083667A1 (fr) |
| KR (1) | KR20160075826A (fr) |
| CN (1) | CN105829340A (fr) |
| AP (1) | AP2016009267A0 (fr) |
| AR (1) | AR098615A1 (fr) |
| AU (1) | AU2014366425B2 (fr) |
| BR (1) | BR112016010635A2 (fr) |
| CA (1) | CA2930596A1 (fr) |
| CR (1) | CR20160227A (fr) |
| DO (1) | DOP2016000142A (fr) |
| EA (1) | EA201690966A1 (fr) |
| HK (1) | HK1224305A1 (fr) |
| IL (1) | IL245491A0 (fr) |
| MA (1) | MA39110B1 (fr) |
| MX (1) | MX2016007988A (fr) |
| PE (1) | PE20160847A1 (fr) |
| PH (1) | PH12016501183A1 (fr) |
| SG (1) | SG11201604237PA (fr) |
| TN (1) | TN2016000208A1 (fr) |
| TW (1) | TW201609128A (fr) |
| WO (1) | WO2015094876A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI622596B (zh) | 2015-10-26 | 2018-05-01 | 美國禮來大藥廠 | 升糖素受體促效劑 |
| WO2019140024A1 (fr) | 2018-01-12 | 2019-07-18 | Eli Lilly And Company | Polythérapie |
| CA3128922A1 (fr) | 2019-02-05 | 2020-08-13 | Eli Lilly And Company | Agonistes analogiques du glucagon et leurs procedes d'utilisation |
| MA55504A (fr) | 2019-04-01 | 2022-02-09 | Novo Nordisk As | Anticorps dirigés contre le liraglutide et leur utilisation |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2477286C2 (ru) | 2007-01-05 | 2013-03-10 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | АНАЛОГИ ГЛЮКАГОНА, ОБЛАДАЮЩИЕ ПОВЫШЕННОЙ РАСТВОРИМОСТЬЮ В БУФЕРАХ С ФИЗИОЛОГИЧЕСКИМ ЗНАЧЕНИЕМ pH |
| EP2249853A4 (fr) * | 2008-01-30 | 2012-12-26 | Univ Indiana Res & Tech Corp | Promédicaments peptidiques à base d' esters |
| US8450270B2 (en) * | 2008-06-17 | 2013-05-28 | Indiana University Research And Technology Corporation | Glucagon analogs exhibiting enhanced solubility and stability in physiological pH buffers |
| US8703701B2 (en) * | 2009-12-18 | 2014-04-22 | Indiana University Research And Technology Corporation | Glucagon/GLP-1 receptor co-agonists |
| UA126465C2 (uk) * | 2011-06-10 | 2022-10-12 | Ханмі Сайенс Ко., Лтд. | Пептид, що має активність оксинтомодуліну, та фармацевтична композиція для лікування ожиріння, яка його містить |
| WO2013004983A1 (fr) * | 2011-07-04 | 2013-01-10 | Imperial Innovations Limited | Nouveaux composés et leurs effets sur le comportement alimentaire |
-
2014
- 2014-12-04 AR ARP140104513A patent/AR098615A1/es unknown
- 2014-12-05 TW TW103142473A patent/TW201609128A/zh unknown
- 2014-12-11 US US15/103,130 patent/US20160311882A1/en not_active Abandoned
- 2014-12-11 AU AU2014366425A patent/AU2014366425B2/en not_active Ceased
- 2014-12-11 WO PCT/US2014/069644 patent/WO2015094876A1/fr not_active Ceased
- 2014-12-11 BR BR112016010635A patent/BR112016010635A2/pt not_active IP Right Cessation
- 2014-12-11 HK HK16112378.9A patent/HK1224305A1/zh unknown
- 2014-12-11 EP EP14821418.2A patent/EP3083667A1/fr not_active Withdrawn
- 2014-12-11 PE PE2016000771A patent/PE20160847A1/es not_active Application Discontinuation
- 2014-12-11 CA CA2930596A patent/CA2930596A1/fr not_active Abandoned
- 2014-12-11 MA MA39110A patent/MA39110B1/fr unknown
- 2014-12-11 AP AP2016009267A patent/AP2016009267A0/en unknown
- 2014-12-11 TN TN2016000208A patent/TN2016000208A1/en unknown
- 2014-12-11 CN CN201480069406.3A patent/CN105829340A/zh active Pending
- 2014-12-11 KR KR1020167015880A patent/KR20160075826A/ko not_active Withdrawn
- 2014-12-11 SG SG11201604237PA patent/SG11201604237PA/en unknown
- 2014-12-11 EA EA201690966A patent/EA201690966A1/ru unknown
- 2014-12-11 MX MX2016007988A patent/MX2016007988A/es unknown
-
2016
- 2016-05-05 IL IL245491A patent/IL245491A0/en unknown
- 2016-05-18 CR CR20160227A patent/CR20160227A/es unknown
- 2016-06-15 DO DO2016000142A patent/DOP2016000142A/es unknown
- 2016-06-17 PH PH12016501183A patent/PH12016501183A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN105829340A (zh) | 2016-08-03 |
| EA201690966A1 (ru) | 2016-12-30 |
| PH12016501183A1 (en) | 2016-07-25 |
| MA39110B1 (fr) | 2018-04-30 |
| US20160311882A1 (en) | 2016-10-27 |
| IL245491A0 (en) | 2016-06-30 |
| EP3083667A1 (fr) | 2016-10-26 |
| AR098615A1 (es) | 2016-06-01 |
| BR112016010635A2 (pt) | 2017-12-05 |
| CA2930596A1 (fr) | 2015-06-25 |
| TW201609128A (zh) | 2016-03-16 |
| AP2016009267A0 (en) | 2016-06-30 |
| DOP2016000142A (es) | 2016-07-15 |
| HK1224305A1 (zh) | 2017-08-18 |
| AU2014366425B2 (en) | 2016-12-08 |
| TN2016000208A1 (en) | 2017-10-06 |
| CR20160227A (es) | 2016-07-12 |
| KR20160075826A (ko) | 2016-06-29 |
| WO2015094876A1 (fr) | 2015-06-25 |
| MX2016007988A (es) | 2016-09-09 |
| PE20160847A1 (es) | 2016-09-10 |
| SG11201604237PA (en) | 2016-07-28 |
| AU2014366425A1 (en) | 2016-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA37740A1 (fr) | Seringue | |
| CR20150418A (es) | Compuestos de tetrahidropirrolotiazina | |
| EA201692271A1 (ru) | Терапевтически активные соединения и способы их применения | |
| AR095097A1 (es) | Compuestos de fenoxietoxi | |
| EA201691983A1 (ru) | Пиридин-2-амиды, пригодные в качестве агонистов cb2 | |
| CO7141429A2 (es) | Nuevos compuestos de pirazol | |
| EA201690763A1 (ru) | Лечение рака поджелудочной железы | |
| MA39110B1 (fr) | Nouveau composé pour le traitement de l'hypoglycémie grave | |
| MA39109B1 (fr) | Nouveau composé pour le traitement de l'hypoglycémie grave | |
| MA42166B1 (fr) | Seringue | |
| MA39108A1 (fr) | Nouveau composé pour le traitement de l'hypoglycémie sévère | |
| MA39019A1 (fr) | Acétate de 4-{4-[(1e)-4-(2,9-diazaspiro[5.5]undéc-2-yl)but-1-én-1-yl]-2-méthylbenzyl}-5-(propan-2-yl)-1h-pyrazol-3-yl-bêta-d-glucopyranoside | |
| EA201690214A1 (ru) | Способ лечения гипертрофической кардиомиопатии | |
| MA39432B1 (fr) | Dérivé de tetrahydropyrrolo[3,4-d][1,3]thiazine en tant qu'inhibiteur de bace | |
| EA201690593A1 (ru) | Новые соединения мочевины | |
| UA113753C2 (xx) | Фенілзаміщені кетоеноли для боротьби з паразитами риб | |
| MA38931A1 (fr) | Utilisation de l'odiparcil dans le traitement d'une mucopolysaccharidose | |
| EA201600013A1 (ru) | Основание ковша и ковш | |
| MA38411B1 (fr) | Inhibiteurs de cdc7 |